Skip to main content
. 2007 Jul;5(4):305–309. doi: 10.1370/afm.707

Table 1.

Demographic and Clinical Characteristics of Herpes-Zoster Patients With and Without Serological Confirmation (n=260)

Characteristic With Confirmed HZ (n=236) Without Confirmed HZ (n=24) Univariable OR (95% CI) Multivariable OR (95% CI)
Age, mean (SD), y 66.5 (9.7) 63.9 (9.9) 1.03 (0.98–1.08) 1.05 (0.99–1.10)
Female sex, No. (%) 133 (56.4) 13 (54.2) 1.09 (0.47–2.54) 0.88 (0.32–2.39)
Duration of rash at examination, mean (SD), d 2.7 (1.7) 1.9 (1.9) 1.39 (1.04–1.85) 1.60 (1.13–2.29)
Severity of rash at examination*
    Mild, No. (%) 88 (37.3) 19 (79.2)
    Moderate/severe, No. (%) 144 (61.0) 5 (20.8) 6.22 (2.24–17.25) 5.21 (1.75–15.54)
Localization
    Other, No. (%) 59 (25.0) 8 (33.3)
    Thoracic, No. (%) 177 (75.0) 16 (66.7) 1.50 (0.61–3.68) 2.14 (0.73–6.29)
Duration of prodromal pain, mean (SD), d 2.4 (3.9) 2.5 (2.7) 0.99 (0.89–1.11) 1.04 (0.88–1.22)
Severity of pain, mean (SD) 48.3 (26.9) 46.9 (28.0) 1.00 (0.99–1.02) 0.99 (0.98–1.02)

HZ = herpes zoster; OR = odds ratio; CI = confidence interval.

* Dermatome was unknown in 4 patients with serological confirmation of herpes zoster.

† Reference category.

‡ Visual analog scale, range 0-100.